SCHEMBL6766574

SCHEMBL6766574

CCCc1nn(-c2cccc(OC)c2)c2c1C(=O)CC(C(C)C)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
SLC5A1 P13866 3/20 0.38
USP2 O75604 1/20 0.37
GSK3B P49841 1/20 0.37
S1PR4 O95977 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
S1PR1 P21453 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DCTPP1 Q9H773 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6772551 0.89 DHODH (0.37) ALDH1A1LMNAS1PR4HPGDS1PR1
SCHEMBL6770490 0.88 ALDH1A1 (0.42) ALDH1A1LMNASLC5A1HTTRAB9A
SCHEMBL6766537 0.87 ALDH1A1 (0.41) ALDH1A1LMNASLC5A1USP2GSK3B
SCHEMBL6165346 0.86 ALDH1A1 (0.40) ALDH1A1LMNASLC5A1MAPK1KMT2A
SCHEMBL6770505 0.85 OPRM1 (0.46) HTTRAB9AKMT2ASMN1; SMN2NPSR1
SCHEMBL6770636 0.84 RIPK2 (0.35) SLC5A1HTTRAB9AKMT2ASMN1; SMN2
SCHEMBL6777339 0.83 CASP1 (0.39) ALDH1A1LMNAGSK3BS1PR4HPGD
SCHEMBL6770575 0.82 GPBAR1 (0.39) HTTRAB9AKMT2ASMN1; SMN2HSD17B10
SCHEMBL6766674 0.82 RIPK2 (0.46) ALDH1A1LMNAS1PR4HPGDS1PR1
SCHEMBL6767248 0.80 DHODH (0.35) ALDH1A1LMNAKMT2ANPSR1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed